How life sciences companies are measuring their ESG impact

EY Health Sciences & Wellness podcast series

EY에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 EY 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

1+ y ago 26:02

MP3•에피소드 홈

In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact. Together they review the growing importance of sustainable health solutions, ESG in healthcare and sustainability reporting in the Health Sciences and Wellness industry. Learn how ESG reporting and the information flow that helps businesses successfully engage with their stakeholders. The conversation also explores global use cases, the significance of banking for impact, and the gaps in impact measurement that need attention in the coming years. Uncover the multitude of metrics available in sustainability reporting, the growing importance of sustainability metrics, and their potential to drive transformative conversations.

10 에피소드